9980 Huennekens Street
United States - Map
TearLab Corp. operates as an ophthalmic device company in the United States. It develops and markets lab-on-a-chip technologies that enable eye care practitioners to enhance standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The companys TearLab Osmolarity System is a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The companys system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.
|Mr. Elias Vamvakas ,
Chairman, Chief Exec. Officer and Sec.
|Mr. Joseph Jensen ,
Pres and Chief Operating Officer
|Mr. Paul Smith ,
VP of International Markets
|Dr. Venkiteshwar S. Manoj Ph.D.,
VP of Medical Affairs
|Dr. Richard L. Lindstrom M.D.,
Scientific Advisor, Director and Chairman of Compensation Committee
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in CAD.|